|
|
|
Volumn 42, Issue 1090, 2000, Pages 97-100
|
|
Drugs for prevention and treatment of postmenopausal osteoporosis
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVELLA;
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM;
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
ESTRADIOL;
ESTRADIOL PLUS NORETHISTERONE ACETATE;
ESTROGEN DERIVATIVE;
FEMHRT;
GESTAGEN;
GYNODIOL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MEDROXYPROGESTERONE;
MENAST;
NORGESTIMATE;
ORTHO PREFEST;
PARATHYROID HORMONE;
PIPERAZINE ESTRONE SULFATE;
PREMPHASE;
RALOXIFENE;
RISEDRONIC ACID;
SALCATONIN;
VITAMIN D;
BREAST CANCER;
CALCIUM INTAKE;
CLINICAL TRIAL;
DENSITOMETRY;
DRUG APPROVAL;
DRUG CLEARANCE;
DRUG COST;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INDICATION;
DRUG INDUCED DISEASE;
ENDOMETRIUM CANCER;
FLUSHING;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL DISEASE;
HORMONAL THERAPY;
HUMAN;
NAUSEA;
POSTMENOPAUSE OSTEOPOROSIS;
REVIEW;
RHINITIS;
THROMBOEMBOLISM;
UTERUS BLEEDING;
VITAMIN INTAKE;
ABSORPTIOMETRY, PHOTON;
AGED;
ALENDRONATE;
BONE DENSITY;
BONE RESORPTION;
BREAST NEOPLASMS;
CALCITONIN;
CALCIUM;
CALCIUM CHANNEL BLOCKERS;
CLINICAL TRIALS;
DENSITOMETRY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ESTROGENS;
ETIDRONIC ACID;
FEMALE;
HUMAN;
MIDDLE AGE;
OSTEOPOROSIS, POSTMENOPAUSAL;
RALOXIFENE;
RISK FACTORS;
VITAMIN D;
|
|
EID: 0034676032
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|